Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease

NCT03703856 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Memantine

Sponsor

University of California, San Diego